Hamacher, R., Lanzafame, H., Mavroeidi, I. A., Pabst, K. M., Kessler, L., Cheung, P. F., . . . Fendler, W. P. (2023). Fibroblast Activation Protein Inhibitor Theranostics: The Case for Use in Sarcoma. PET Clinics, 18(3), 361-367. https://doi.org/10.1016/j.cpet.2023.02.008
Chicago Style (17th ed.) CitationHamacher, Rainer, et al. "Fibroblast Activation Protein Inhibitor Theranostics: The Case for Use in Sarcoma." PET Clinics 18, no. 3 (2023): 361-367. https://doi.org/10.1016/j.cpet.2023.02.008.
MLA (8th ed.) CitationHamacher, Rainer, et al. "Fibroblast Activation Protein Inhibitor Theranostics: The Case for Use in Sarcoma." PET Clinics, vol. 18, no. 3, 2023, pp. 361-367, https://doi.org/10.1016/j.cpet.2023.02.008.
Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.
Visit our Citation Styles guide for help on properly citing sources.